Continuous Erector Spinae Plane Blocks to Treat Pain Following Percutaneous Nephrolithotomy

Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Nov 15, 2021

Keywords

ClinConnect Summary

Enrollment. Participants will be consenting adults undergoing percutaneous nephrolithotomy. Study inclusion will be proposed to eligible patients prior to surgery. If a patient desires study participation, written, informed consent will be obtained. The study population of interest includes women and men of all races, ethnicity, sexual identity, and socioeconomic status. Of note, the investigators will be using local anesthetic, perineural catheters, and infusion pumps as approved/cleared and do not plan to research a possible change of indication or use of these medications/devices as part...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • undergoing unilateral percutaneous nephrolithotomy in the prone position
• • analgesic plan includes a single-injection erector spinae plane block
• • age 18 years or older
• Exclusion Criteria:
• • morbid obesity as defined by a body mass index \> 40 (BMI=weight in kg / \[height in meters\]2)
• • renal insufficiency (abnormal preoperative creatinine or estimated glomerular filtration rate)
• • chronic opioid use (daily use within the 2 weeks prior to surgery and duration of use \> 4 weeks)
• • history of opioid abuse
• • any comorbidity which results in moderate or severe functional limitation
• • inability to communicate with the investigators or hospital staff
• • pregnancy
• • bilateral or multi-stage surgical procedures
• • incarceration
• • known allergy to any study medication
• • any contraindication to perineural catheter insertion (e.g., infection at the catheter insertion site)